Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK

Bone

Volumn 49, Issue 6, 2011, Pages 1152-1159

  Hie, Mamiko ^a   Iitsuka, Natsumi ^a   Otsuka, Tomoyo ^a   Nakanishi, Atsuko ^a   Tsukamoto, Ikuyo ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Osteoblastogenesis; Osteoclastogenesis; RANK; Wnt catenin pathway; Zinc deficiency

Indexed keywords

BETA CATENIN; COLONY STIMULATING FACTOR 1; DICKKOPF 1 PROTEIN; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN KINASE B; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SP1; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; BONE METABOLISM; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FEMUR; GENE EXPRESSION; INSULIN BLOOD LEVEL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TIBIA; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

ACID PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; FEMUR; ISOENZYMES; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; RATS; RATS, WISTAR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, INSULIN; RNA, MESSENGER; STAINING AND LABELING; TRANSCRIPTION FACTORS; ZINC;

EID: 81355160603     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.08.019     Document Type: Article

References (52)

1. Cousins R.J. A role of zinc in the regulation of gene expression. Proc Nutr Soc 1998, 57:307-311.
2. Seco C., Revilla M., Hernandez E.R., Gervas J., Gonzalez-Riola J., Villa L.F., et al. Effects of zinc supplementation on vertebral and femoral bone mass in rats on strenuous treadmill training exercise. J Bone Miner Res 1998, 13:508-512.
3. Ovesen J., Moller-Madsen B., Thomsen J.S., Danscher G., Mosekilde L. The positive effects of zinc on skeletal strength in growing rats. Bone 2001, 29:565-570.
4. Rossi L., Migliaccio S., Corsi A., Marzia M., Bianco P., Teti A., et al. Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition. J Nutr 2001, 131:1142-1146.
5. Wang X., Fosmire G.J., Gay C.V., Leach R.M. Short-term zinc deficiency inhibits chondrocyte proliferation and induces cell apoptosis in the epiphyseal growth plate of young chickens. J Nutr 2002, 132:665-673.
6. MacDonald R.S. The role of zinc in growth and cell proliferation. J Nutr 2000, 130:1500S-1508S.
7. Relea P., Revilla M., Ripoll E., Arribas I., Villa L.F., Rico H. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 1995, 24:303-307.
8. Eberle J., Schmidmayer S., Erben R.G., Stangassinger M., Roth H.P. Skeletal effects of zinc deficiency in growing rats. J Trace Elem Med Biol 1999, 13:21-26.
9. Rico H., Villa L.F. Zinc, a new coherent therapy for osteoporosis?. Calcif Tissue Int 2000, 67:422-423.
10. Elmstahl S., Gullberg B., Janzon L., Johnell O., Elmstahl B. Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc. Osteoporos Int 1998, 8:333-340.
11. Erben R.G., Lausmann K., Roschger P., Schuler C., Skalicky M., Klaushofer K., et al. Long-term marginal zinc supply is not detrimental to the skeleton of aged female rats. J Nutr 2009, 139:703-709.
12. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000, 21:115-137.
13. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.
14. Udagawa N., Takahashi N., Akatsu T., Tanaka H., Sasaki T., Nishihara T., et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A 1990, 87:7260-7264.
15. Harada S., Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-355.
16. Asagiri M., Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007, 40:251-264.
17. Kishi S., Yamaguchi M. Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 1994, 48:1225-1230.
18. Yamaguchi M., Uchiyama S. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Int J Mol Med 2004, 14:81-85.
19. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
20. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006, 99:1233-1239.
21. Miyama K., Yamada G., Yamamoto T.S., Takagi C., Miyado K., Sakai M., et al. A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. Dev Biol 1999, 208:123-133.
22. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003, 309:689-694.
23. Kim Y.J., Lee M.H., Wozney J.M., Cho J.Y., Ryoo H.M. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 2004, 279:50773-50780.
24. Ilouz R., Kaidanovich O., Gurwitz D., Eldar-Finkelman H. Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun 2002, 295:102-106.
25. Yavropoulou M.P., Yovos J.G. The role of the Wnt signaling pathway in osteoblast commitment and differentiation. Hormones (Athens) 2007, 6:279-294.
26. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
27. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
28. Goto A., Tsukamoto I. Increase in tartrate-resistant acid phosphatase of bone at the early stage of ascorbic acid deficiency in the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat. Calcif Tissue Int 2003, 73:180-185.
29. Hie M., Shimono M., Fujii K., Tsukamoto I. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone 2007, 41:1045-1050.
30. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
31. Sato T., Shibata T., Ikeda K., Watanabe K. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 2001, 16:2215-2221.
32. Hie M., Yamazaki M., Tsukamoto I. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes. Eur J Pharmacol 2009, 621:1-9.
33. Sudo T., Nishikawa S., Ogawa M., Kataoka H., Ohno N., Izawa A., et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995, 11:2469-2476.
34. Hayashi S., Miyamoto A., Yamane T., Kataoka H., Ogawa M., Sugawara S., et al. Osteoclast precursors in bone marrow and peritoneal cavity. J Cell Physiol 1997, 170:241-247.
35. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 1999, 190:1741-1754.
36. Lean J.M., Davies J.T., Fuller K., Jagger C.J., Kirstein B., Partington G.A., et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003, 112:915-923.
37. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106:852-859.
38. Hie M., Tsukamoto I. Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. J Nutr Biochem 2011, 22:164-171.
39. Hie M., Iitsuka N., Otsuka T., Tsukamoto I. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. Eur J Pharmacol 2011, 668:140-146.
40. Ishii J., Kitazawa R., Mori K., McHugh K.P., Morii E., Kondo T., et al. Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF. J Cell Biochem 2008, 105:896-904.
41. Zhang D.E., Hetherington C.J., Chen H.M., Tenen D.G. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 1994, 14:373-381.
42. Yamaguchi M., Goto M., Uchiyama S., Nakagawa T. Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions. Mol Cell Biochem 2008, 312:157-166.
43. Takada T., Suzuki N., Ito-Kato E., Noguchi Y., Ito M., Maeno M., et al. Effect of beta-alanyl-L-histidinato zinc on the differentiation of C2C12 cells. Life Sci 2004, 76:509-520.
44. Kwun I.S., Cho Y.E., Lomeda R.A., Shin H.I., Choi J.Y., Kang Y.H., et al. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation. Bone 2010, 46:732-741.
45. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 2005, 102:3324-3329.
46. Scott D.A. Crystalline insulin. Biochem J 1934, 28:1592-1602. [1].
47. Tang X., Shay N.F. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr 2001, 131:1414-1420.
48. Haase H., Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 2005, 18:333-338.
49. Seino S., Seino M., Nishi S., Bell G.I. Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci U S A 1989, 86:114-118.
50. Daughaday W.H., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989, 10:68-91.
51. Werner H., Hernandez-Sanchez C., Karnieli E., Leroith D. The regulation of IGF-I receptor gene expression. Int J Biochem Cell Biol 1995, 27:987-994.
52. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 1996, 16:1035-1046.